Abbvie
Samantha Neville
Field Access Specialist - Northeast
Cell:(727) 401-9924
Venclexta https://www.venclexta.com/cll/support-and-resources/financial-support.html

GlaxoSmithKline
Michael Savoia
Northeast Oncology FRM
Managed Markets & Government Affairs
5 Moore Drive, PO Box 13398, RTP, NC 27709-3398
United States
Email michael.j.savoia@gsk.com
Cell 914-588-3473
www.togetherwithgskoncology.com

Guardant Health

Joana Buxhaku

Account Executive, Boston North – MA, NH, ME, VT

Mobile +1 781 219 8511

Email: clientservices@guardanthealth.com

https://guardant360cdx.com/practice-resources/

Agios Pharmaceuticals

Nefar Moran

Patient Support Manager

Nefar.moran@agios.com

1-800-951-3889

Heron Therapeutics
Michelle Wollersheim
Director, National Accounts /Reimbursement
C: 414-687-5624
E: mwollersheim@herontx.com

CINVANTI® (aprepitant) injectable emulsion
SUSTOL® (granisetron) extended-release injection

https://www.heronconnect.com/

Alexion

Jen Ulven

Field Reimbursement Manager

1-904-874-3344
Jen.Ulven@Alexion.com

https://alexiononesource.com/

Incyte

Marcy Gingerich

Field Access Manager, McKesson

740-405-2240

Marcy.Gingerich@McKesson.com

Jakafi (ruxolitinib)

Pemazyre (pemigatinib)

Zynyz (retifanlimab-dlwr)

www.IncyteCARES.com 

855-452-5234

Monjuvi (tafasitamab-cxix)

www.MyMissionSupport.com

855-421-6172

Feraheme Assist

Feraheme IV Iron

Mariaelena Galie

Senior Manager, Patient Services

mgalie@amahpharma.com

267-275-1185

https://www.feraheme.com/patient-support/

Ipsen
Melissa Kramer
Regional Reimbursement Director
978-701-8568
Email:melissa.kramer@ipsen.com

Somatuline Depot(Lanreotide),  and Onivyde(Irinotecan Liposome Injection)

Amgen
Trish Hansen

Field Reimbursement Specialist

781-815-2694
Tricia.Hansen@xcenda.com
Amgen Assist 360
1-888-427-7478

Janssen 
Ward Bennett
Healthcare Policy and Advocacy Director
Strategic Customer Group
Johnson & Johnson
Health Care Systems Inc.
8 Bloody Brook Rd
Amherst NH 03031 USA
T: 603-672-9381
M: 603-345-1404
wbennett@its.jnj.com
http://www.janssencarepath.com/
DARZALEX® (daratumumab), YONDELIS® (trabectedin), ZYTIGA® (abiraterone acetate), DOXIL® (doxorubicin HCl liposome injection), PROCRIT® (epoetin alfa), and SYLVANT® (siltuximab),ERLEADA® (apalutamide).

Janssen Compass^TM support program dedicated to patients who have been prescribed either ERLEADA® (apalutamide), DARZALEX® (daratumumab), or DARZALEX Faspro®  (daratumumab and hyaluronidase-fihj) https://www.janssencompass.com 

Astellas
Kevin Kobylinski
Access and Reimbursement Manager
NH/VT/ME/MA/CT/RI
C: 603-502-8175
E-mail: kevin.kobylinski@Astellas.com 
PADCEV™ (enfortumab vedotin-ejfv), Xospata® (gilteritinib), Xtandi® (enzalutamide) 
https://www.astellaspharmasupportsolutions.com/

Jazz Pharmaceuticals 
Lynn Monte
Access & Reimbursement Manager
Hematology/Oncology
Jazz Pharmaceuticals
3170 Porter Drive
Palo Alto, CA 94304
508-873-1445
Lynn.monte@jazzpharma.com
www.jazzcares.com

AstraZeneca/MedImmune 

Jenifer N. McNulty 
Field Reimbursement Manager 
MA, ME, NH, VT, RI 
Cell 617.818.3517
 jenifer.mcnulty@astrazeneca.com
Imfinzi, Tagrisso, Lynparza, Calquence, Faslodex,  Imjudo, Iressa, Enhertu

Joann Dousa, RPh, AE-C

Field Reimbursement Manager, Oncology

Connecticut, Upstate New York, Western MA

Cell: 508-813-2834

Joann.Dousa@astrazeneca.com
Imfinzi, Tagrisso, Lynparza, Calquence, Faslodex, Imjudo Iressa, Enhertu

Aveo Oncology

Caroline Ward, RN, BSN

Oncology Account Manager-New England

cward@aveooncology.com

603-707-6223

Product: Fotivda (tivozanib)

AVEO ACE Program- Access Center of Excellence

www.fotivda.com to enroll

1-833-Fotivda (1-833-368-4832)

Lilly USA
Mary E. Mergy, MBA
Oncology Field Reimbursement Manager – Northeast
Eli Lilly and Company
314.601.7421 (mobile)
mergy_mary@lilly.com
https://www.lillyoncologysupport.com
Cyramza (ramucirumab), Alimta (pemetrexed), Erbitux (cetuximab),Retevmo (Selpercatinib), Verzenio (abemaciclib), Portrazza (necitumumab)

Bayer
Jerry George
Field Reimbursement Manager
Bayer Oncology
(716) 308-4143, cell
(585) 492-5261, fax
jerry.george@bayer.com
Xofigo, Nexavar, Nubeqa,Stivarga and Aliqopa

Nexavar Patient Assistance

Stivarga Patient Assistance

Xofigo Patient Assistance  
Aliqopa Patient Assistance

Vitrakvi Patient Assistance
Nubeqa Patient Assistance

Merck
Field Reimbursement

Michael Keyes

Field Reimbursement Manager

Mobile: (814) 823-3097

Email: michael.keyes@merck.com

Mark Montello
Medicare Account Executive

Mark.Montello@merck.com
603-321-1145

BeiGene
Jeff Wilhour
Director, Field Market Access
Cell: 410-804-2619
jeff.wilhour@beigene.com
Brukinsa Patient Support
1-833-234-4363
Brukinsa

Novartis Oncology

Elizabeth Gugliotta

Associate Director Access & Reimbursement

Elizabeth.Gugliotta@novartis.com

Cell: 401-480-9905

https://www.hcp.novartis.com

Blueprint Medicines

Fred Richards

Key Account Manager – New England

Blueprint Medicines

781-258-1457

frichards@blueprintmedicines.com

https://yourblueprint.com/

BMS Access Support 
James Blanchard

Manager, Access & Reimbursement Manager
Manchester, NH (ME, NH, VT)
Cell (207) 232-3395
james.blanchard@bms.com
www.BMSAccessSupport.com

Oncology
Abraxane, Opdivo, Opdualag, Yervoy

Hematology
Empliciti, Idhifa, Inrebic, Onureg, Pomalyst, Reblozyl, Revlimid, Sprycel

Oncopeptides 
Kelly Draveling
National Account Executive
kelly.draveling@oncopeptides.com
816-522-2032

PEPAXTO (melphalan flufenamide)

www.OnCoursesupport.com

Boehringer-Ingelheim

Cathy Berry
Reimbursement Access Associate Director
Cell Phone: 716 481 1563
E-mail: catherine.berry@boehringer-ingelheim.com
Gilotrif: https://www.gilotrifhcp.com/starting-your-patient
Gilotrif Commercial Co-Pay 

For more information on the BI Cares Foundation, call 1-855-297-5906 or visit www.boehringer-ingelheim.us/our-responsibility/patient-assistance-program

Pharmacyclics
Jason Hart

Field Access Specialist – Northeast

Cell: 603-777-6362

Email: Jason.hart@abbvie.com

IMBRUVICA (ibrutinib) Patient Access & Support Services: www.imbruvicabyyourside.com

Caris Life Sciences

Nicole Esposito

Account Manager

Mobile: 207-303-4204

Email: nespositol@carisls.com

Patient Access Page: https://www.carislifesciences.com/patients/

Patient Financial Services: https://www.carislifesciences.com/patients/financial-services/

Pfizer
Julie Rogers, MBA, CRT, CPC

Field Reimbursement Manager
Pfizer Oncology
860-422-0420
Julie.rogers@pfizer.com

Pfizer Patient Assistance: 

PfizerOncologyTogether.com

www.Pfizerpro.com

Besponsa, Bosulif, Braftovi, Daurismo, Ibrance, Inlyta, Lorbrena, Mektovi, Mylotarg, Retacrit, Talzenna, Vizimpro, Xalkori

Reimbursement Support and Co-pay assistance only: Aromasin, Nivestym, Nyvepria, Ruxience, Trazimera, Zirabev

Clovis Oncology

Katheryne Murray
Practice Experience Manager- Northeast

Cell: 860-876-5568

kmurray@clovisoncology.com

www.rubracaconnections.com

Rubraca® (rucaparib)

Puma Biotechnology

Daniel Coffey
603-312-1676
dcoffey@pumabiotechnology.com
NERLYNX® (neratinib)
https://nerlynx.com/hcp/access-and-support

Coherus Biosciences, Inc.
Teri Nisbet, CPC, CHONC
Field Reimbursement Specialist
Phone: 727-599-4998
tnisbet@coherus.com
www.coherussolutions.com

Regeneron
Jeanne Leahy
Phone: 215-285-0068
Email: Jeanne.leahy@sanofi.com
Libtayo: Libtayo Surround

Jill Coyle, MBA, BSN, RN

Senior Oncology Territory Manager

Oncology Breast

211 Mount Airy Road

Basking Ridge, NJ 07920 

Mobile +207-272-2598

icoyle@dsi.com

Rigel Pharmaceuticals 

Kent Main 
​Senior Territory Business Manager
Me/NH/VT North Shore Mass.
207-841-5156 cell
kmain@rigel.com

Rigel One Care

Dova Pharmaceuticals

Richard DeBone
Director- Market Access
Dova Pharmaceuticals
rdebone@dova.com
724.953.9661

Sandoz Biopharmaceuticals
Andrew Palsha
Reimbursement Policy Manager
508 735-1941
andrew.palsha@sandoz.com
https://www.sandozonesource.com/

Eisai

Niya Prabhu

Sr Manager, Access & Reimbursement

niya_prabhu@eisai.com

917.232.5956

Lenvima and Halaven 

Eisai Assistance Program

For program and eligibility information, and to review the program terms and conditions, please visit eisaireimbursement.com or call 1-866-61-EISAI (1-866-613-4724)

Sanofi
Mike Brooks
Regional Account Manager
484-686-9380
mike.brooks@sanofi.com

Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase)

CareASSIST

EMD Serono

Walter Serafin, MA, BA

Associate Director, Field Patient Services - Oncology 

EMD Serono, Inc.

Mobile: (339) 214-6080

Office: (913) 322-6063

walter.serafin@emdserono.com

One Technology Place

Rockland, MA. 02370

For Bavencio:

CoverOne.com

Phone: (844) Cover1 or (844) 826-8371

Monday-Friday: 8:00am-8:00pm ET

For Tepmetko:

OncNavigationCenter.com

Phone: 1-844-662-3631 (844-ONC-EMD1) 
Fax: 844-501-0062

Monday–Friday: 8:00 am–8:00 pm ET

Seagen

Michelle L. Vallee

Senior Oncology Account Manager

(207)229-6702

mvallee@seagen.com

www.SeagenSecure.com

Epizyme

Scott Obenshain, MBA

Associate Director of Epigenetic Therapy

sobenshain@epizyme.com

(716) 998-5662(cell)

TAZVERIK™ (tazemetostat)

EpizymeNOW  or 1-833-4EPINOW (437-4669)

Servier
Wendy Poage
Patient Advocacy
Oncaspar, Asparlas, Tibsovo
Wendy.Poage@servier.com
617-335-7987

For help with access and financial assistance, call 800-813-5905 or visit ServierOne.com.

Exelixis 

Michele Sofarelli Luther

Associate Director, Patient Access

CABOMETYX.com
207-838-2364 
msofarelli@exelixis.com 
Exelixis Access Services

Sobi

Kara Olenio – Health System Director

Kara.Olenio@sobi.com

603-843-7336

Genentech
​Paul Villarreal

Cell: 475-254-6532

E-mail: Villarreal.Paul@gene.com
https://www.genentech-access.com
copayassistancenow.com
https://www.gene.com/patients/patient-foundation
855-MYCOPAY (855-692-6729)

mycareroadmap.com

Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab)

Oral Products: ALECENSA® (alectinib), COTELLIC® (cobimetinib), ERIVEDGE® (vismodegib),GAVRETO (pralsetinib),ROZLYTREK® (entrectinib), TARCEVA® (erlotinib), VENCLEXTA™ (venetoclax) ZELBORAF® (vemurafenib)

Subcutaneous Products: ​HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), ​PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human)

Stemline Therapeutics
Angela Johnson
Field Reimbursement Manager, Northeast
Cell: 724-858-6285
ajohnson@stemline.com
ELZONRIS
www.elzonris.com
Stemline ARC Patient Assistance

Taiho Oncology

Bob Stewart
Director, Market Access
Taiho Oncology, Inc.
101 Carnegie Center, Suite 101
Princeton, NJ 08540
609 575-5169
rstewart@taihooncology.com https://www.taihooncologycopay.com/

Dan Monteith
Regional Oncogenomic Liaison
Genomic Health
m 650.722.7043 or 866.613.3015
f 603.488.5565
dmonteith@genomichealth.com

Gilead

Melissa McLean
Field Reimbursement Senior Manager (Northeast)
M: (914) 715-7535
Email: melissa.mclean1@gilead.com
Zydelig (idelalisib)
https://www.zydeligaccessconnect.com/patient
1-844-622-2377
Yescarta (axicabtagene ciloleucel)
https://www.yescarta.com/support#kite-konnect

1-844-454-5483

TRODELVY
Access Services: https://trodelvy.com/patient/access-services

Kate Friday
Director Patient Services

Kate.Friday@tevapharm.com
973-214-8394

US ACT Parsippany, NJ

www.tevacore.com

TG Therapeutics 

Kelly Bucklen

Kelly.bucklen@tgtxinc.com

401.261.5262

www.Ukoniq.com/patientsupport

Ukoniq (Umbralisib)